GB0025058D0 - Composition - Google Patents
CompositionInfo
- Publication number
- GB0025058D0 GB0025058D0 GBGB0025058.9A GB0025058A GB0025058D0 GB 0025058 D0 GB0025058 D0 GB 0025058D0 GB 0025058 A GB0025058 A GB 0025058A GB 0025058 D0 GB0025058 D0 GB 0025058D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0025058.9A GB0025058D0 (en) | 2000-10-12 | 2000-10-12 | Composition |
AU2001262163A AU2001262163A1 (en) | 2000-10-12 | 2001-03-26 | Composition |
PCT/EP2001/003786 WO2002030458A1 (en) | 2000-10-12 | 2001-03-26 | Yersinia adhesion protein as vaccine adjuvant |
ARP010101488A AR027738A1 (en) | 2000-10-12 | 2001-03-28 | COMPOSITION COADYUVANTE, COMPOSITIONS OF VACCINES THAT INCLUDE SUCH COMPOSITION COADYUVANTE; PROCEDURE FOR INDUCTION OF IMMUNE IMMUNORESPUESTAS AMMAMIFEROS AND PROCEDURE OF TREATMENT WHERE SUCH VACCINES APPLY |
CO01025486A CO5270014A1 (en) | 2000-10-12 | 2001-03-30 | COMPOSITION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0025058.9A GB0025058D0 (en) | 2000-10-12 | 2000-10-12 | Composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0025058D0 true GB0025058D0 (en) | 2000-11-29 |
Family
ID=9901176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0025058.9A Ceased GB0025058D0 (en) | 2000-10-12 | 2000-10-12 | Composition |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR027738A1 (en) |
AU (1) | AU2001262163A1 (en) |
CO (1) | CO5270014A1 (en) |
GB (1) | GB0025058D0 (en) |
WO (1) | WO2002030458A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2854803B1 (en) * | 2003-05-16 | 2005-06-24 | Aventis Pasteur | VACCINE COMPOSITION COMPRISING IRON PHOSPHATE AS VACCINE. |
JP2010502747A (en) * | 2006-09-08 | 2010-01-28 | ベクトン・ディキンソン・アンド・カンパニー | A stable powder formulation of alum-adsorbed vaccine |
EP2034022A1 (en) | 2007-09-10 | 2009-03-11 | Universite Libre De Bruxelles | Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus |
EP2045263A1 (en) | 2007-10-02 | 2009-04-08 | Universite Libre De Bruxelles | Identification and molecular characterisation of salivary metalloproteases expressed in the tick salivary glands |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5239066A (en) * | 1985-07-31 | 1993-08-24 | The Board Of Trustees Of Leland Stanford Jr. University | Yersinia ail nucleic acids |
US5338842A (en) * | 1985-07-31 | 1994-08-16 | The Board Of Trustees Of Leland Stanford Jr. University | Yersinia INV nucleic acids |
WO2000018355A2 (en) * | 1998-09-30 | 2000-04-06 | Walter Reed Army Institute Of Research | Use of purified invaplex from gram negative bacteria as a vaccine |
ATE290012T1 (en) * | 1998-10-21 | 2005-03-15 | Univ Kansas Ct For Res Inc | METHOD FOR PRODUCING PURIFIED INVASIN PROTEIN AND ITS APPLICATION |
-
2000
- 2000-10-12 GB GBGB0025058.9A patent/GB0025058D0/en not_active Ceased
-
2001
- 2001-03-26 AU AU2001262163A patent/AU2001262163A1/en not_active Abandoned
- 2001-03-26 WO PCT/EP2001/003786 patent/WO2002030458A1/en active Application Filing
- 2001-03-28 AR ARP010101488A patent/AR027738A1/en unknown
- 2001-03-30 CO CO01025486A patent/CO5270014A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2001262163A1 (en) | 2002-04-22 |
WO2002030458A8 (en) | 2002-07-18 |
AR027738A1 (en) | 2003-04-09 |
CO5270014A1 (en) | 2003-04-30 |
WO2002030458A1 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0026018D0 (en) | New composition | |
HUP0400589A3 (en) | Colostrum-based composition | |
SG99895A1 (en) | Proanthocyanidin-containing composition | |
EP1320385A4 (en) | Combination compositions | |
IL145793A0 (en) | Odor-eliminating composition | |
GB0023891D0 (en) | Composition | |
EP1270611A4 (en) | Composition | |
GB0019651D0 (en) | Compositions | |
GB0109427D0 (en) | Arthropod-controlling composition | |
GB0003232D0 (en) | Novel composition | |
IL150471A0 (en) | Composition | |
AU2001287852A8 (en) | Composition | |
GB0004518D0 (en) | Compositions | |
GB0007762D0 (en) | Composition | |
GB0025058D0 (en) | Composition | |
GB0031267D0 (en) | Novel compositions | |
GB0004522D0 (en) | Compositions | |
GB0119165D0 (en) | Composition | |
GB0020913D0 (en) | Composition | |
GB0014187D0 (en) | Composition | |
GB0023420D0 (en) | Composition | |
GB0030376D0 (en) | Composition | |
GB0031483D0 (en) | Composition | |
GB0023418D0 (en) | Composition | |
GB0023416D0 (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |